Sigma-Aldrich Corporation (SIAL):企業のM&A・提携動向(医療機器分野)

【英語タイトル】Sigma-Aldrich Corporation (SIAL) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDME2457D)・商品コード:GDME2457D
・発行会社(調査会社):GlobalData
・発行日:2016年2月24日
・ページ数:63
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アメリカ
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

Sigma-Aldrich Corporation (Sigma-Aldrich) is a life sciences and technology company. It offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research such as genomic and proteomic research, diagnosis of diseases, pharmaceutical development and biotechnology. The company offers its solutions to biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, chemical and electronics companies, besides hospitals. It operates in 37 countries in the Americas, Asia, Europe, Australia and Africa, besides Israel through wholly-owned subsidiaries, and markets its products in 160 countries. Sigma-Aldrich is headquartered in St. Louis, the US.

Sigma-Aldrich Corporation (SIAL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Sigma-Aldrich Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Sigma-Aldrich Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Sigma-Aldrich Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Sigma-Aldrich Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Sigma-Aldrich Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Sigma-Aldrich Corporation, Medical Equipment, Deal Details 12
Asset Purchase 12
Sigma-Aldrich to Acquire Duolink Product Portfolio from Olink Bioscience 12
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 13
Partnerships 14
Sigma Aldrich Enters Into Licensing Agreement With HealthLinx 14
Proteome Sciences Enters Into License Agreement With Sigma-Aldrich 15
Sigma-Aldrich Enters into Distribution Agreement with LGC 16
Sigma-Aldrich and GenapSys to Co-Market Genius system 17
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 18
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 19
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 20
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 21
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 22
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 23
Diffinity Genomics Enters Into Distribution Agreement With Sigma-Aldrich 24
Sigma Life Science Signs An Agreement With Kraig Biocraft Labs 25
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 26
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 28
Sigma Life Science Enters Into Licensing Agreement With King’s College London 29
Debt Offering 30
Sigma-Aldrich Completes An Underwritten Public Offering Of Senior Notes Due 2020 For US$300 Million 30
Asset Transactions 32
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 32
Acquisition 34
Merck Acquires Sigma-Aldrich for USD17 Billion 34
Sigma-Aldrich Acquires Cell Marque 37
Sigma-Aldrich Completes Acquisition Of BioReliance For US$350 Million 38
Sigma-Aldrich Acquires Resource Technology 40
Sigma-Aldrich Corporation – Key Competitors 41
Key Employees 42
Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 46
Strategy And Business Planning 46
Aug 27, 2015: Sigma-Aldrich Announces Agreement with Public Health England to Manufacture and Supply NCTC/NCPF Certified Reference Materials 46
May 12, 2015: SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling 47
Apr 17, 2015: Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia 48
Jan 29, 2015: Sigma-Aldrich and the Institute of Molecular Genetics, Czech Center for Phenogenomics, Establish CRISPR Core Lab Collaboration 49
Jan 22, 2015: Sigma-Aldrich and VIB Form Alliance to Provide Scientists with Enhanced and Faster Access to Novel Translational Research Tools 50
Financial Announcements 51
Feb 12, 2015: Sigma-Aldrich Reports Q4 2014 Results and Full-Year 2014 Results 51
Legal and Regulatory 54
Jul 23, 2015: Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 54
Other Significant Developments 55
Nov 04, 2015: Sigma-Aldrich Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services 55
Nov 03, 2015: Sigma-Aldrich Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00 56
May 07, 2015: Sigma-Aldrich Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend. 58
May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement 60
Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche 61
Mar 19, 2015: Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
Sigma-Aldrich Corporation, Medical Equipment, Key Facts, 2014 1
Sigma-Aldrich Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Sigma-Aldrich Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Sigma-Aldrich Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Sigma-Aldrich Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Sigma-Aldrich Corporation, Deals By Market, 2010 to YTD 2016 9
Sigma-Aldrich Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Sigma-Aldrich to Acquire Duolink Product Portfolio from Olink Bioscience 12
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies 13
Sigma Aldrich Enters Into Licensing Agreement With HealthLinx 14
Proteome Sciences Enters Into License Agreement With Sigma-Aldrich 15
Sigma-Aldrich Enters into Distribution Agreement with LGC 16
Sigma-Aldrich and GenapSys to Co-Market Genius system 17
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 18
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 19
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 20
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 21
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 22
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 23
Diffinity Genomics Enters Into Distribution Agreement With Sigma-Aldrich 24
Sigma Life Science Signs An Agreement With Kraig Biocraft Labs 25
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 26
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 28
Sigma Life Science Enters Into Licensing Agreement With King's College London 29
Sigma-Aldrich Completes An Underwritten Public Offering Of Senior Notes Due 2020 For US$300 Million 30
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 32
Merck Acquires Sigma-Aldrich for USD17 Billion 34
Sigma-Aldrich Acquires Cell Marque 37
Sigma-Aldrich Completes Acquisition Of BioReliance For US$350 Million 38
Sigma-Aldrich Acquires Resource Technology 40
Sigma-Aldrich Corporation, Key Competitors 41
Sigma-Aldrich Corporation, Key Employees 42
Sigma-Aldrich Corporation, Subsidiaries 44

List of Figures
Sigma-Aldrich Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Sigma-Aldrich Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Sigma-Aldrich Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Sigma-Aldrich Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Sigma-Aldrich Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Sigma-Aldrich Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Sigma-Aldrich Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Sigma-Aldrich Corporation, Medical Equipment, Deals by Market, 2010 to YTD 2016 9

★調査レポート[Sigma-Aldrich Corporation (SIAL):企業のM&A・提携動向(医療機器分野)] (コード:GDME2457D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Sigma-Aldrich Corporation (SIAL):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆